Live website intelligence
Angelman Syndrome Foundation - Home
Angelman syndrome (AS) is a rare neuro‑developmental disorder that affects one in 15,000 people. Our mission is to advance the awareness and treatment of AS with the ultimate goal of finding a cure.
Last refresh
Updated 15d ago
Analyst read
Professional
Detected stack
Quick read
angelman.org looks like health & wellness. Traffic signals point to roughly 22.0K monthly visits. Current AI trust scoring is 5/100.
What to do next
51/56 fields populated (91%)
Providers with missing fields
visual: 4/4
All expected fields present
meta: 3/3
All expected fields present
seo: 5/5
All expected fields present
dns: 4/4
All expected fields present
ads: 5/5
All expected fields present
publisher: 3/5
Missing: directCount, resellerCount
files: 2/3
Missing: robotsSitemapUrls
traffic: 10/10
All expected fields present
whois: 6/6
All expected fields present
radar: 2/4
Missing: categories, sourceTimestamp
ai: 7/7
All expected fields present
Keep exploring
Good pSEO pages should not strand the visitor. These links keep the journey moving through adjacent directories and comparable live reports.
Browse Health & Wellness sites
Move from this single report into the broader market cluster.
Browse Rare Diseases & Genetic Disorders sites
Use the topic route when audience and editorial intent matter more than category.
Browse Wordpress websites
Pivot from one domain into a stack-based discovery path.
Browse Cloudflare websites
Pivot from one domain into a stack-based discovery path.
Why this module matters
Use the business tab to understand trust, monetization, audience fit, and brand posture before you spend time on outreach, partnerships, or competitive teardown work.
A nonprofit foundation dedicated to advancing awareness, treatment, and research for Angelman syndrome, a rare neuro-developmental genetic disorder, with the ultimate goal of finding a cure.
Monetization Signals
Nonprofit/Charitable Foundation model detected
Low trust with 5/100 score
Families affected by Angelman syndrome, caregivers, medical professionals, researchers, donors, and advocates for rare disease communities